08-20-2018 09:25 AM CET - Advertising, Media Consulting, Marketing Research
Print

Cancer Tumor Profiling Market Outlook 2018 by Top Player Analysis (Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp.)

Press release from: Data Bridge Market Research
Global Cancer Tumor Profiling Market
Global Cancer Tumor Profiling Market


Global Cancer Tumor Profiling Market study with depth analysis, describing about the Service & Industry demand and explain market outlook and status to 2025. The market Study is segmented by key regions which are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are dominating the Market by its Growth, Share Values and Many More

The report Describes by size, industry status, scope and Demand forecast, competition landscape and growth opportunity. This research report categorizes the Global Cancer Tumor Profiling Market
by companies, region, type and end-use industry.

Download Free Sample Report Copy at databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Cancer Tumor Profiling Market By Technology (Next-generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, In Situ Hybridization{Fluorescence in Situ Hybridization, Chromogenic in Situ Hybridization}, Microarray), By Technique (Genomics, Proteomics, Epigenetics, Metabolomics), By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications), By Geography – Industry Trends and Forecast to 2024.

Major Market Competitors:

Some of the major players operating in global cancer tumor profiling market are

• Helomics Corp.,
• NanoString Technologies, Inc.,
• Oxford Gene Technology,
• Abbott,
• BD,
• Illumina, Inc.,
• Qiagen N.V.,
• F. Hoffmann-La Roche AG,
• NeoGenomics Laboratories, Inc.,
• HTG Molecular Diagnostics, Inc.,
• Genomic Health Inc. ,
• Caris Life Sciences,
• Hologic, Inc.,
• Siemens Medical Solutions USA Inc.,
• Personal Genome Diagnostics, Inc.,
• FOUNDATION MEDICINE, INC.,
• Contextual Genomics,
• AGENDIA,
• Perthera, Inc.,
• ApoCell,
• GenScript,
• Ribomed,
• Boreal Genomics Inc.,
• Biotheranostics and
• Proteome Sciences among others.

To Avail 10% Discount On This Report Mail us at sopan.gedam@databridgemarketresearch.com

Global Cancer Tumor Profiling Market accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Detailed TOC: Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Request for Detailed TOC at databridgemarketresearch.com/toc/?dbmr=global-cancer-tumo...

Competitive Analysis:

The global cancer tumor profiling market is fragmented with the presence of a large number of players across different regions. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Major Market Drivers and Restraints:

• Technological advancements for identifying the cancer tumors.
• Increasing the cancer incidences.
• Increase in demand for next generation sequencing technique in cancer profiling.
• Lack of Skilled Professionals and Infrastructure
• Growth in demand of personalized medicines
• Increase in the use of biomarkers in tumor profiling.
• Availability of Funding for Cancer Research

Market Segmentation:

The global cancer tumor profiling market is segmented by technology into:-

• Next-Generation Sequencing,
• Polymerase Chain Reaction,
• Immunohistochemistry,
• In Situ Hybridization and Microarray.
o Fluorescence In Situ Hybridization And
o Chromogenic In Situ Hybridization.

By Application the market is segmented into:-

• Personalized Medicine,
• Diagnostics,
• Biomarker Discovery,
• Prognostics and
• Research Applications.

By Technique the market is segmented in:-

• Genomics,
• Proteomics,
• Epigenetics and
• Metabolomics.

Inquiry before buying: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1187448 • Views: 173
More releasesMore releases

You can edit or delete your press release here: